Bone Biologics BBLGW Stock
Bone Biologics Price Chart
Bone Biologics BBLGW Financial and Trading Overview
| Bone Biologics stock price | 18.08 USD |
| Previous Close | 17.5 USD |
| Open | 9.97 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 18.08 - 18.08 USD |
| 52 Week Range | 8.3 - 35.95 USD |
| Volume | 1.16K USD |
| Avg. Volume | 307 USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.527 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.144 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BBLGW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.036728 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bone Biologics Stock Price History
| Beta (5Y Monthly) | 0.527 |
| 52-Week Change | 30.59% |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 35.95 USD |
| 52 Week Low | 8.3 USD |
| 50-Day Moving Average | 18.9 USD |
| 200-Day Moving Average | 17.51 USD |
BBLGW Share Statistics
| Avg. Volume (3 month) | 307 USD |
| Avg. Daily Volume (10-Days) | 500 USD |
| Shares Outstanding | N/A |
| Float | 1.79M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.87% |
| Return on Equity (ttm) | -70.17% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3108991 USD |
| Diluted EPS (ttm) | -0.144 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.33M USD |
| Total Cash Per Share (mrq) | 2.97 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 13.847 |
| Book Value Per Share (mrq) | 2.995 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2691150 USD |
| Levered Free Cash Flow (ttm) | -1650181 USD |
Profile of Bone Biologics
| Country | United States |
| State | MA |
| City | Burlington |
| Address | 2 Burlington Woods Drive |
| ZIP | 01803 |
| Phone | 781 552 4452 |
| Website | https://www.bonebiologics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 2 |
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Q&A For Bone Biologics Stock
What is a current BBLGW stock price?
Bone Biologics BBLGW stock price today per share is 18.08 USD.
How to purchase Bone Biologics stock?
You can buy BBLGW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bone Biologics?
The stock symbol or ticker of Bone Biologics is BBLGW.
How many shares does Bone Biologics have in circulation?
The max supply of Bone Biologics shares is 0.
What is Bone Biologics Price to Earnings Ratio (PE Ratio)?
Bone Biologics PE Ratio is now.
What was Bone Biologics earnings per share over the trailing 12 months (TTM)?
Bone Biologics EPS is -0.144 USD over the trailing 12 months.